Closing the knowledge gap on cardiovascular disease in type 2 diabetes: the EMPA-REG OUTCOME trial and beyond

Por Oral, Elif A
Publicado no Drugs Context (2016)

Insufficient Sensitivity of Hemoglobin A(1C) (A1C) Determination in Diagnosis or Screening of Early Diabetic States

Por Fajans, Stefan S., Herman, William H., Oral, Elif A.
Publicado em 2010

A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin

Por Lebastchi, Jasmin, Ajluni, Nevin, Neidert, Adam, Oral, Elif A.
Publicado no J Clin Endocrinol Metab (2015)

The Effects of Atypical Antipsychotic Usage Duration on Serum Adiponectin Levels and Other Metabolic Parameters

Por Oral, Elif, Gulec, Mustafa, Kurt, Nezahat, Yilmaz, Sumeyra, Aydin, Nazan, Kirpinar, Ismet
Publicado no Eurasian J Med (2011)

Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program

Por Ajluni, Nevin, Dar, Moahad, Xu, John, Neidert, Adam H, Oral, Elif A
Publicado no J Diabetes Metab (2016)

Development of a Psychometric Instrument Based on the Inference-Based Approach to Obsessive-Compulsive Disorder: The Obsessional Probabilistic Inference Scale

Por GÜLEÇ, Mustafa, DEVECİ, Erdem, BEŞİROĞLU, Lutfullah, BOYSAN, Murat, KALAFAT, Temel, ORAL, Elif
Publicado no Noro Psikiyatr Ars (2014)

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

Por Chiquette, Elaine, Oral, Elif A, Garg, Abhimanyu, Araújo-Vilar, David, Dhankhar, Praveen
Publicado no Diabetes Metab Syndr Obes (2017)

Can we predict agitation in patients with suicide attempts in the emergency department?

Por Akoz, Ayhan, Gur, Sultan Tuna Akgol, Oral, Elif, Avsar, Ummu Zeynep, Emet, Mucahit
Publicado no Afr Health Sci (2016)

Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome

Por Walden, Patrick, Jiang, Qingmei, Jackson, Elizabeth A, Oral, Elif A, Weintraub, Martha S, Rubenfire, Melvyn
Publicado no Diabetes Metab Syndr Obes (2016)

Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study

Por Kumar, Aditi, Blackshear, Chad, Subauste, Jose S., Esfandiari, Nazanene H., Oral, Elif Arioglu, Subauste, Angela R.
Publicado no J Endocr Soc (2017)

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Por Chan, Jean L., Koda, Joy, Heilig, Joseph S., Cochran, Elaine K., Gorden, Phillip, Oral, Elif A., Brown, Rebecca J.
Publicado no Clin Endocrinol (Oxf) (2016)

Lamin A/C Maintains Exocrine Pancreas Homeostasis by Regulating Stability of RB and Activity of E2F

Por Elenbaas, Jared S., Cunha, Juliana Bragazzi, Azuero-Dajud, Rodrigo, Nelson, Bradley, Oral, Elif A., Williams, John A., Stewart, Colin L., Omary, M. Bishr
Publicado no Gastroenterology (2018)

Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy

Por Brown, Rebecca J., Oral·, Elif A., Cochran, Elaine, Araújo-Vilar, David, Savage, David B., Long, Alison, Fine, Gregory, Salinardi, Taylor, Gorden, Phillip
Publicado no Endocrine (2018)

Effects of Exogenous Leptin on Satiety and Satiation in Patients with Lipodystrophy and Leptin Insufficiency

Por McDuffie, Jennifer R., Riggs, Patti A., Calis, Karim A., Freedman, Renee J., Oral, Elif A., DePaoli, Alex M., Yanovski, Jack A.
Publicado em 2004

Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations

Por Subauste, Angela R., Das, Arun K., Li, Xiangquan, Elliot, Brandon, Evans, Charles, El Azzouny, Mahmoud, Treutelaar, Mary, Oral, Elif, Leff, Todd, Burant, Charles F.
Publicado em 2012

Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan

Por Lager, Corey J., Esfandiari, Nazanene H., Subauste, Angela R., Kraftson, Andrew T., Brown, Morton B., Cassidy, Ruth B., Bellers, Darlene, Lockwood, Amy L., Varban, Oliver A., Oral, Elif A.
Publicado no Obes Surg (2017)

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

Por Petersen, Kitt Falk, Oral, Elif Arioglu, Dufour, Sylvie, Befroy, Douglas, Ariyan, Charlotte, Yu, Chunli, Cline, Gary W., DePaoli, Alex M., Taylor, Simeon I., Gorden, Phillip, Shulman, Gerald I.
Publicado em 2002

Roux-En-Y Gastric Bypass Vs. Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss

Por Lager, Corey J., Esfandiari, Nazanene H., Subauste, Angela R., Kraftson, Andrew T., Brown, Morton B., Cassidy, Ruth B., Nay, Catherine K., Lockwood, Amy L., Varban, Oliver A., Oral, Elif A.
Publicado no Obes Surg (2016)

THE CLINICAL APPROACH TO THE DETECTION OF LIPODYSTROPHY – AN AACE CONSENSUS STATEMENT

Por Handelsman, Yehuda, Oral, Elif A., Bloomgarden, Zachary T., Brown, Rebecca J., Chan, Jean L., Einhorn, Daniel, Garber, Alan J., Garg, Abhimanyu, Garvey, W. Timothy, Grunberger, George, Henry, Robert R., Lavin, Norman, Tapiador, Carmen D., Weyer, Christian
Publicado em 2013

Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis

Por Sahinoz, Melis, Khairi, Shafaq, Cuttitta, Ashley, Brady, Graham F., Rupani, Amit, Meral, Rasimcan, Tayeh, Marwan K., Thomas, Peedikayil, Riebschleger, Meredith, Camelo-Piragua, Sandra, Innis, Jeffrey W., Bishr Omary, M., Michele, Daniel E., Oral, Elif A.
Publicado no Clin Diabetes Endocrinol (2018)